Mangoceuticals received a 180-day extension from Nasdaq to comply with the minimum $1 bid price rule, now due by February 1, 2027. The extension follows Nasdaq's confirmation that Mangoceuticals meets other listing requirements and the company's plan to possibly use a reverse stock split to regain compliance. Meanwhile, Mangoceuticals is progressing with a business combination with Nuclea Energy, which develops advanced nuclear microreactor technology aimed at powering AI and data centers. This merger could open new growth avenues in the clean energy sector for Mangoceuticals and its shareholders.
REalloys (ALOY) is rated a speculative Buy due to its potential to commercialize non-Chinese rare earths by 2028. The company holds $119 million in cash and is expanding its SRC facility, supporting near-term execution. However, the key risk remains ...
Robo.ai's industrial group Alif Holding plans to establish Alif Maritec, a wholly owned subsidiary in the UAE focused on maritime protection, smart ports, underwater intelligence, and critical infrastructure protection. Led by Dr. Jasem Al-Mansory, A...
T2 Metals Corp. has engaged Geomorphic AI to conduct an AI-supported review of drill targets at its 100%-owned Cora Copper Project in Arizona, a region known for significant copper deposits. The project lies near major copper mines and has historical...
VIAVI Solutions will showcase its comprehensive data center testing portfolio at ECOC 2026 in Malaga, Spain, highlighting innovations in silicon photonics, co-packaged optics, and AI fabric validation. Their new products address the growing complexit...
Inflection Resources has finished 92 air core drill holes totaling 16,434 meters at its Trangie Project in New South Wales, revealing promising signs of gold-copper mineralization. The company also completed a gravity survey and started an IP-MT geop...
